Company Filing History:
1 out of 192 
Years Active: 2011-2025
Title: Arndt Schmitz: Innovator in Oncology and Pharmaceutical Development
Introduction
Arndt Schmitz is a notable inventor based in Berlin, Germany. He has made significant contributions to the fields of oncology and pharmaceutical development. With a total of 2 patents, Schmitz has focused on innovative solutions that address critical health challenges.
Latest Patents
One of Schmitz's latest patents is titled "Identification of candidate signs indicative of an NTRK oncogenic fusion." This invention relates to identifying candidate signs within patient data that indicate the presence of an NTRK oncogenic fusion. The subject matter includes a computer-implemented method, a system, and a non-transitory computer-readable storage medium designed to determine a probability value from patient data. This value indicates the likelihood of a patient suffering from cancer due to a mutation of a neurotrophic receptor tyrosine kinase (NTRK) gene.
Another significant patent is "3-amino-pyrazolo[3,4b]pyridines as inhibitors of protein tyrosine kinases, their production and use as pharmaceutical agents." This invention involves compounds that serve as inhibitors of protein tyrosine kinases for treating various diseases. The patent details the use of these compounds and their production processes, highlighting their potential as pharmaceutical agents.
Career Highlights
Arndt Schmitz has worked with prominent companies in the pharmaceutical industry, including Bayer Schering Pharma AG and Bayer Intellectual Property GmbH. His experience in these organizations has contributed to his expertise in developing innovative medical solutions.
Collaborations
Throughout his career, Schmitz has collaborated with notable professionals in the field, including Wolfgang Schwede and Hermann Kuenzer. These collaborations have further enhanced his contributions to the industry.
Conclusion
Arndt Schmitz is a distinguished inventor whose work in oncology and pharmaceutical development has led to valuable patents. His innovative approaches continue to impact the medical field positively.